tiprankstipranks
Kamada Ltd. Q1 Financial Results and Conference Call
Company Announcements

Kamada Ltd. Q1 Financial Results and Conference Call

Kamada Ltd (IL:KMDA) has released an update.

Don't Miss our Black Friday Offers:

Kamada Ltd., a leading biopharmaceutical company, will unveil its financial outcomes for Q1 2024 on May 8 before the U.S. markets open and will host a conference call to discuss the results. The company, known for its specialty in plasma-derived products, has a significant commercial presence distributing FDA-approved biopharmaceuticals globally and is also progressing with an investigational inhaled AAT treatment in late-stage clinical trials.

For further insights into IL:KMDA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskKamada’s Strong Growth and Strategic Expansion in 2024
TheFlyKamada reports Q3 EPS 7c, consensus 7c
TheFlyKamada sees FY24 revenue $158M-$162M, consensus $160.47M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App